Cargando…

Follicular T-cell lymphoma mimicking lymphocyte-rich classic Hodgkin lymphoma: a case report of a diagnostic pitfall

Follicular T-cell lymphoma (FTCL), one of the nodal T-cell lymphomas with T follicular helper (T((FH))) phenotype, is an uncommon disease. The diagnosis of FTCL is challenging on the distinction from the morphological mimics mostly exemplified by follicular lymphoma. Here, we described a case of FTC...

Descripción completa

Detalles Bibliográficos
Autores principales: Sakakibara, Ayako, Suzuki, Yuka, Kato, Harumi, Yamamoto, Kazuhito, Sakata-Yanagimoto, Mamiko, Ishikawa, Yuichi, Furukawa, Katsuya, Shimada, Kazuyuki, Kohno, Kei, Nakamura, Shigeo, Satou, Akira, Kato, Seiichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: JSLRT 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8265489/
https://www.ncbi.nlm.nih.gov/pubmed/33716241
http://dx.doi.org/10.3960/jslrt.20052
Descripción
Sumario:Follicular T-cell lymphoma (FTCL), one of the nodal T-cell lymphomas with T follicular helper (T((FH))) phenotype, is an uncommon disease. The diagnosis of FTCL is challenging on the distinction from the morphological mimics mostly exemplified by follicular lymphoma. Here, we described a case of FTCL that mimicked lymphocyte-rich classic Hodgkin lymphoma (LRCHL). A 47-year-old male presented with cervical lymphadenopathy. The biopsy specimen demonstrated nodular lymphoid proliferation, which included scattered CD30+ CD15- CD20- PAX5 weakly+ Hodgkin and Reed-Sternberg (HRS)-like cells and a rich distribution of CD3+ CD4+ PD1+ T-cells. Epstein Barr virus was not detected in HRS-like cells, but it was detected in a small proportion of the scattered lymphocytes. The large cells were also negative for programmed cell death ligand 1, which appeared to be coincidental as described in our previous report of LRCHL. However, flow cytometry showed a CD3- CD4+ T-cell population that constituted 37.4% of all gated lymphocytes. A PCR analysis showed a clonal T-cell receptor-gamma gene rearrangement, but not a clonal immunoglobulin heavy chain gene rearrangement, and showed RHOA G17V mutation. The constellation of these findings led us to revise the diagnosis to FTCL. This result indicated that our case belonged to a relatively indolent subgroup of nodal peripheral T-cell lymphoma of T((FH)) phenotype, which affects patients ≤60 years old, recently proposed by our group. This case report expands our understanding of the morphologic spectrum of FTCL and its clinicopathologic significance.